)

Sumitomo Chemical Company (4005) investor relations material
Sumitomo Chemical Company Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Strategic Business Focus and Growth Initiatives
Emphasis on strengthening core businesses rooted in organic synthesis technology, particularly in agro and life solutions, ICT/mobility solutions, and advanced medical solutions, with a focus on technological advantages for growth and resilience.
Crop protection products Indiflin, Rapidacil, and Pavechto are positioned as future blockbuster chemicals, with significant R&D achievements, global market expansion plans, and sales growth expected by 2030.
Expansion in semiconductor materials, high-purity chemicals, and OLED display materials, leveraging proprietary technology, global manufacturing sites, and targeting a 20% share in cutting-edge resists with doubled sales by 2030.
Regenerative medicine and cell therapy identified as new growth drivers, focusing on iPS cell-based therapies, CDMO business, and blockbuster status for Parkinson’s disease therapy, with NDA filed in Japan and US trials underway.
Structural reforms include divestment from commodity resin businesses, integration of Prime Polymer, financial improvement plans for Petro Rabigh, and a shift to high value-added, eco-friendly products.
Financial and Capital Efficiency Improvements
Medium-term targets set for core operating income of ¥200 billion, ROE of 8%, ROIC of 6%, and D/E ratio of 0.8x, with a focus on ROIC-oriented management and enterprise value enhancement.
Strengthening investment management through data-driven, objective, and agile processes to enhance capital efficiency and reduce impairment risk.
Shareholder returns targeted at a payout ratio over 30% and annual dividend of ¥24 per share or more, contingent on achieving financial goals.
Market and Competitive Landscape
AGL (agro and life solutions) business faces cyclical challenges in key markets like Brazil, North America, and India, with strategies to manage inventory and tariffs.
Chinese competitors are recognized as both a threat and potential partners, especially in advanced technology sectors; innovation and differentiation are prioritized.
Biorational and biostimulant segments are targeted for expansion, particularly in Europe and South America, possibly through acquisitions and aiming to double business scale by 2030.
Next Sumitomo Chemical Company earnings date

Next Sumitomo Chemical Company earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage